Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin.

Hardy RD, Coalson JJ, Peters J, Chaparro A, Techasaensiri C, Cantwell AM, Kannan TR, Baseman JB, Dube PH.

PLoS One. 2009 Oct 27;4(10):e7562. doi: 10.1371/journal.pone.0007562.

2.

Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.

Medina JL, Coalson JJ, Brooks EG, Winter VT, Chaparro A, Principe MF, Kannan TR, Baseman JB, Dube PH.

Am J Respir Cell Mol Biol. 2012 Jun;46(6):815-22. doi: 10.1165/rcmb.2011-0135OC. Epub 2012 Jan 26.

3.

The Immunopathologic Effects of Mycoplasma pneumoniae and Community-acquired Respiratory Distress Syndrome Toxin. A Primate Model.

Maselli DJ, Medina JL, Brooks EG, Coalson JJ, Kannan TR, Winter VT, Principe M, Cagle MP, Baseman JB, Dube PH, Peters JI.

Am J Respir Cell Mol Biol. 2018 Feb;58(2):253-260. doi: 10.1165/rcmb.2017-0006OC.

4.

Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model.

Kannan TR, Coalson JJ, Cagle M, Musatovova O, Hardy RD, Baseman JB.

J Infect Dis. 2011 Nov 15;204(10):1596-604. doi: 10.1093/infdis/jir557. Epub 2011 Sep 28.

5.

Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.

Techasaensiri C, Tagliabue C, Cagle M, Iranpour P, Katz K, Kannan TR, Coalson JJ, Baseman JB, Hardy RD.

Am J Respir Crit Care Med. 2010 Sep 15;182(6):797-804. doi: 10.1164/rccm.201001-0080OC. Epub 2010 May 27.

6.

Mycoplasma pneumoniae Community Acquired Respiratory Distress Syndrome toxin expression reveals growth phase and infection-dependent regulation.

Kannan TR, Musatovova O, Balasubramanian S, Cagle M, Jordan JL, Krunkosky TM, Davis A, Hardy RD, Baseman JB.

Mol Microbiol. 2010 Jun 1;76(5):1127-41. doi: 10.1111/j.1365-2958.2010.07092.x. Epub 2010 Feb 28.

7.

Mycoplasma pneumoniae CARDS toxin elicits a functional IgE response in Balb/c mice.

Medina JL, Brooks EG, Chaparro A, Dube PH.

PLoS One. 2017 Feb 15;12(2):e0172447. doi: 10.1371/journal.pone.0172447. eCollection 2017.

8.

Mycoplasma pneumoniae Community-Acquired Respiratory Distress Syndrome Toxin Uses a Novel KELED Sequence for Retrograde Transport and Subsequent Cytotoxicity.

Ramasamy K, Balasubramanian S, Manickam K, Pandranki L, Taylor AB, Hart PJ, Baseman JB, Kannan TR.

MBio. 2018 Jan 23;9(1). pii: e01663-17. doi: 10.1128/mBio.01663-17.

9.

ADP-ribosylation of NLRP3 by Mycoplasma pneumoniae CARDS toxin regulates inflammasome activity.

Bose S, Segovia JA, Somarajan SR, Chang TH, Kannan TR, Baseman JB.

MBio. 2014 Dec 23;5(6). pii: e02186-14. doi: 10.1128/mBio.02186-14.

10.

Annexin A2 mediates Mycoplasma pneumoniae community-acquired respiratory distress syndrome toxin binding to eukaryotic cells.

Somarajan SR, Al-Asadi F, Ramasamy K, Pandranki L, Baseman JB, Kannan TR.

MBio. 2014 Aug 19;5(4). pii: e01497-14. doi: 10.1128/mBio.01497-14.

11.

Mycoplasma pneumoniae CARDS toxin exacerbates ovalbumin-induced asthma-like inflammation in BALB/c mice.

Medina JL, Coalson JJ, Brooks EG, Le Saux CJ, Winter VT, Chaparro A, Principe MF, Solis L, Kannan TR, Baseman JB, Dube PH.

PLoS One. 2014 Jul 24;9(7):e102613. doi: 10.1371/journal.pone.0102613. eCollection 2014.

12.

Functional mapping of community-acquired respiratory distress syndrome (CARDS) toxin of Mycoplasma pneumoniae defines regions with ADP-ribosyltransferase, vacuolating and receptor-binding activities.

Kannan TR, Krishnan M, Ramasamy K, Becker A, Pakhomova ON, Hart PJ, Baseman JB.

Mol Microbiol. 2014 Aug;93(3):568-81. doi: 10.1111/mmi.12680. Epub 2014 Jul 10.

13.

Structure of CARDS toxin, a unique ADP-ribosylating and vacuolating cytotoxin from Mycoplasma pneumoniae.

Becker A, Kannan TR, Taylor AB, Pakhomova ON, Zhang Y, Somarajan SR, Galaleldeen A, Holloway SP, Baseman JB, Hart PJ.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5165-70. doi: 10.1073/pnas.1420308112. Epub 2015 Apr 6.

14.

Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice.

Fonseca-Aten M, Ríos AM, Mejías A, Chávez-Bueno S, Katz K, Gómez AM, McCracken GH Jr, Hardy RD.

Am J Respir Cell Mol Biol. 2005 Mar;32(3):201-10. Epub 2004 Dec 30.

PMID:
15626776
15.

Cellular vacuoles induced by Mycoplasma pneumoniae CARDS toxin originate from Rab9-associated compartments.

Johnson C, Kannan TR, Baseman JB.

PLoS One. 2011;6(7):e22877. doi: 10.1371/journal.pone.0022877. Epub 2011 Jul 29.

16.

Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.

Ríos AM, Mejías A, Chávez-Bueno S, Fonseca-Aten M, Katz K, Hatfield J, Gómez AM, Jafri HS, McCracken GH Jr, Ramilo O, Hardy RD.

Antimicrob Agents Chemother. 2004 Aug;48(8):2897-904.

17.
18.

NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection.

Segovia JA, Chang TH, Winter VT, Coalson JJ, Cagle MP, Pandranki L, Bose S, Baseman JB, Kannan TR.

Infect Immun. 2017 Dec 19;86(1). pii: e00548-17. doi: 10.1128/IAI.00548-17. Print 2018 Jan.

19.

Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma.

Peters J, Singh H, Brooks EG, Diaz J, Kannan TR, Coalson JJ, Baseman JG, Cagle M, Baseman JB.

Chest. 2011 Aug;140(2):401-407. doi: 10.1378/chest.11-0221. Epub 2011 May 26.

20.

Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.

Salvatore CM, Fonseca-Aten M, Katz-Gaynor K, Gomez AM, Mejias A, Somers C, Chavez-Bueno S, McCracken GH, Hardy RD.

Infect Immun. 2007 Jan;75(1):236-42. Epub 2006 Oct 30.

Supplemental Content

Support Center